Table 2.
PO1 respiratory performance throughout the study.
| MIP | SMIP | ID | FVC | FVC % predicted | FEV1 | FEV1 % predicted | PEF | PEF % predicted | MEP | |
|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 50 | 196 | 9.9 | 1.71 | 28% | 1.68 | 33% | 3.51 | 31% | 50 |
| Week 2 | 59 | 208 | 9.1 | 1.9 | 32% | 1.87 | 37% | 4.22 | 38% | 46 |
| Week 3 | 61 | 244 | 8.9 | 1.8 | 31% | 1.73 | 35% | 3.97 | 36% | 45 |
| Week 4 | 60 | 235 | 10.7 | 1.85 | 31% | 1.82 | 36% | 3.35 | 30% | 48 |
| Follow-up | 64 | 248 | 10 | 1.91 | 32% | 1.82 | 36% | 4.01 | 36% | 50 |
| Actual change | 14 | 52 | 0.1 | 0.2 | 4% | 0.14 | 3% | 0.5 | 5% | 0 |
| Percent change | 28% | 26.5% | 1% | 11.7% | 8.3% | 14.2% | 0% |
MIP maximal inspiratory pressure measured in cmH2O, SMIP sustained MIP measured in pressure time units, ID inspiratory duration measured in seconds, FVC forced vital capacity measured in liters, FVC % Predicted percent of predicted FVC based on NHANES criteria, FEV1 forced expiratory volume in one second measured in liters, FEV1 % Predicted percent of predicted FEV1 based on NHANES criteria, PEF peak expiratory flow measured in liters/second, PEF % Predicted percent of predicted PEF based on NHANES criteria, MEP maximal expiratory pressure.